| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |